DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: Despite this correlation between increased dysferlin levels and polyol pathway activity, data obtained from dysferlin deficient mice and primary myoblasts from dysferlinopathy patients indicate certain similarities with the metabolic phenotype seen in our nerve damage model33.